Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Hela-Felicitas PetereitHayrettin TumaniUwe K ZettlPublished in: Therapeutic advances in neurological disorders (2021)